Celldex Therapeutics Inc (CLDX)
Cost of Revenue
$0.00
Quarterly · Period ending: · USD
CLDX Cost of Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
CLDX Quarterly Cost of Revenue ($0.00 → $0.00)
Quarterly cost of revenue
High-resolution chart · PNG
CLDX cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 854,000 | |
| 0 | |
| 62,931,000 | |
| 54,196,000 | |
| 52,614,000 | |
| 819,000 | |
| 45,263,000 | |
| 797,000 | |
| 775,000 | |
| 30,426,000 | |
| 767,000 | |
| 26,252,000 | |
| 26,798,000 | |
| 22,899,000 | |
| 21,572,000 | |
| 20,731,000 | |
| 17,056,000 | |
| 14,678,000 | |
| 13,557,000 | |
| 12,356,000 | |
| 12,720,000 | |
| 10,425,000 | |
| 10,708,000 | |
| 9,705,000 | |
| 11,695,000 | |
| 10,339,000 | |
| 11,101,000 | |
| 10,081,000 | |
| 11,151,000 | |
| 10,207,000 | |
| 11,918,000 | |
| 21,448,000 | |
| 21,875,000 | |
| 23,464,000 | |
| 21,915,000 | |
| 24,999,000 | |
| 25,793,000 | |
| 1,000 | |
| 48,867,000 | |
| 49,569,000 | |
| 51,305,000 | |
| -72,260,000 | |
| -71,504,000 | |
| -69,670,000 | |
| -71,035,000 | |
| 27,026,000 | |
| 26,185,000 | |
| 24,100,000 | |
| 24,570,000 | |
| -35,507,000 | |
| -17,424,000 | |
| -22,751,000 | |
| 2,334,000 | |
| 3,551,000 | |
| 3,006,000 | |
| 1,873,000 | |
| 2,344,000 | |
| 2,358,000 | |
| 2,318,000 | |
| 1,941,000 | |
| 2,502,000 | |
| 6,800,000 | |
| 1,218,000 | |
| 1,732,000 | |
| 2,327,000 | |
| 8,397,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 4,958,702 | |
| 0 | |
| 0 | |
| 4,958,702 | |
| 0 | |
| 0 | |
| 0 | |
| 4,348,707 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 10,300 | |
| 17,000 | |
| 13,700 | |
| 10,100 | |
| 8,400 |